BioNano Genomics
在场
BioNano Genomics 是一家在股票代码 BNGO (US) 下上市的公司。
高管
查看带有其 28 名主要高管的组织结构图
BioNano Genomics 搜索最多的简介
- Erik Holmlin, Director, President and Chief Executive Officer
- Kristiina Vuori, Director
- David Barker, Chairman of the Board
高管在BioNano Genomics变化
- Christopher Stewart, Chief Financial Officer, 将于 20239月 退休 (新闻发布的2023八月15号).
- Gülsen Kama已作为Chief Financial Officer加入公司 (新闻发布的2023八月15号).
创建提醒
跟踪 BioNano Genomics 的高管变动
生物技术
BioNano Genomics 拥有 2,287 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Delphia Therapeutics 刚刚宣布为 67 筹款数百万美元。 (公布2024五月7号).
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
BioNano Genomics 的最新新闻稿
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
通过电子邮件
